IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Sanofi

Q3 2025 Holdings

Filed 2025-11-04 | 9 holdings | $260.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
MeiraGTx Holdings plc(MGTX)COMG59665102$100.4M12,197,73738.6%
Novavax(NVAX)COM NEW670002401$59.7M6,880,48122.9%
Inhibrx Biosciences, Inc.(INBX)COM45720N103$39.0M1,157,92615.0%
AnaptysBio(ANAB)COM032724106$25.2M821,9179.7%
Immuneering Corp(IMRX)CLASS A COM45254E107$19.0M2,708,5597.3%
Omada Health Inc.(OMDA)COM68170A108$11.6M524,9034.5%
Lava Therapeutics N.V.SHSN51517105$3.0M1,919,4551.2%
Eledon(ELDN)COM28617K101$2.1M814,9800.8%
Q32 Bio Inc.(QTTB)COM746964105$483.3K244,0830.2%